Experts has a new look! Let us know what you think of the updates.

Provide feedback

Scholarly Works

SUBCUTANEOUS IGF-1 IS NOT BENEFICIAL IN 2-YEAR ALS...

Journal article

SUBCUTANEOUS IGF-1 IS NOT BENEFICIAL IN 2-YEAR ALS TRIAL

Authors

Howe CL; Bergstrom RA; Horazdovsky BF

Journal

Neurology, Vol. 73, No. 15, pp. 1247–1248

Publisher

Wolters Kluwer

Publication Date

October 13, 2009

DOI

10.1212/wnl.0b013e3181b26ae6

ISSN

0028-3878

Associated Experts

Khrista Boylan

Associate Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3209 Neurosciences 3202 Clinical sciences

Medical Subject Headings (MeSH)

Amyotrophic Lateral Sclerosis Animals Clinical Trials as Topic Humans Injections, Subcutaneous Insulin-Like Growth Factor I

View published work (Non-McMaster Users)

View published work (McMaster Users)